Category Archives: Regional News

You are here: Home » Category: "Regional News"

ZH Healthcare Announces blueEHR Mid-Year Growth, Client Expansion, Success

MCLEAN, Va., Aug. 17, 2017 (GLOBE NEWSWIRE) — ZH Healthcare recently reported a significant increase in provider use of blueEHR, the company’s fully-customizable Electronic Health Records (EHR) and electronic health platform. The company notably expanded system capability for major clients, while developing and launching a hospital management system, a telemedicine platform and expanding their workforce…

[Read More]

Globus Medical Announces FDA 510(k) Clearance for Excelsius GPS™

AUDUBON, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced that the Excelsius GPS™, a revolutionary robotic guidance and navigation system, has been 510(k) cleared by the U.S. Food and Drug Administration. This platform technology supports minimally invasive and open orthopedic and neurosurgical procedures, with screw…

[Read More]

Altimmune Announces $14.7 Million Series B Preferred Stock Offering

GAITHERSBURG, Md., Aug. 17, 2017 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced it has entered into a definitive securities purchase agreement with new and existing investors to sell an aggregate of 15,656 shares of Series B convertible preferred stock and warrants.  The gross proceeds to the Company are expected to…

[Read More]

Aclaris Therapeutics to Attend Upcoming Investor Conferences

MALVERN, Pa., Aug. 17, 2017 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology, today announced that members of its management team will present and host investor meetings at the following upcoming investor…

[Read More]

PSI Wins Contract to Provide EBMS Donor Sustainment Services to Support DHA

ARLINGTON, Va., Aug. 16, 2017 (GLOBE NEWSWIRE) — Planned Systems International, Inc. (PSI) — a leading provider of health information technology (IT) solutions to the federal government — announced it has been awarded a $16.2 million task in support of the Department of Defense’s (DoD) mission-essential Enterprise Blood Management System (EBMS) Donor Sustainment Services program….

[Read More]

Novan Appoints Paula Brown Stafford, Chief Development Officer, to Board of Directors

MORRISVILLE, N.C., Aug. 16, 2017 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that Paula Brown Stafford has been appointed to the Company’s Board of Directors, effective immediately. Ms. Stafford joined Novan in March of this year and will continue as the Chief Development Officer, leading clinical development with a focus…

[Read More]

ProPhase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 4,000,000 Shares of Its Common Stock

DOYLESTOWN, Pa., Aug. 15, 2017 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (the “Company” or “ProPhase”), today announced that it intends to commence a tender offer to purchase up to 4,000,000 shares of its common stock at a price per share of $2.30 per share.  The Company…

[Read More]

Supernus Defeats Second Generic Challenger to Oxtellar XR®

ROCKVILLE, Md., Aug. 15, 2017 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced, following a four-day bench trial, that the United States District Court for the District of New Jersey ruled that TWi Pharmaceuticals, Inc. and…

[Read More]

Multiple Postmarket Clinical Studies Nearing Completion in Europe, Supporting Broad Range of Applications for TissuGlu® Surgical Adhesive

RALEIGH, N.C., Aug. 15, 2017 (GLOBE NEWSWIRE) — Six postmarket clinical series studying outcomes associated with the use of TissuGlu Surgical Adhesive in a variety of surgical procedures are nearing completion in Europe. The studies, involving over 200 patients in four European countries, all evaluate TissuGlu in surgical procedures adhering a skin flap to the…

[Read More]